XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities    
Net income $ 71,757 $ 65,017
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 16,017 15,808
Stock option expense 9,091 9,025
Noncash long-term incentive compensation 2,420 9,106
Benefit for deferred income taxes (14,174) (5,422)
Amortization of debt issuance costs 80 80
Changes in operating assets and liabilities:    
(Increase)/decrease in accounts receivable (67,424) 5,345
Decrease in inventories 403 1,302
(Increase)/decrease in prepaid expenses (4,430) 1,909
Decrease in accounts payable and other current liabilities (22,592) (43,012)
Change in current income taxes 37,286 23,871
Net change in lease assets and liabilities 169 25
Decrease/(increase) in other assets 3,034 (12,243)
Increase in other liabilities 951 13,332
Other sources 156 406
Net cash provided by operating activities 32,744 84,549
Cash Flows from Investing Activities    
Capital expenditures (13,280) (12,163)
Business combinations, net of cash acquired (225) (7,300)
Proceeds from sale of fixed assets 112 86
Other uses (281) (8)
Net cash used by investing activities (13,674) (19,385)
Cash Flows from Financing Activities    
Purchases of treasury stock (33,222) (38,460)
Proceeds from exercise of stock options 22,666 37,242
Dividends paid (7,325) (6,050)
Capital stock surrendered to pay taxes on stock-based compensation (6,254) (5,725)
Change in cash overdrafts payable 438 (2,115)
Other sources/(uses) 159 (664)
Net cash used by financing activities (23,538) (15,772)
(Decrease)/increase in Cash and Cash Equivalents (4,468) 49,392
Cash and cash equivalents at beginning of period 178,350 263,958
Cash and cash equivalents at end of period $ 173,882 $ 313,350